HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Archana Monie Selected Research

Investigational Therapies (Experimental Therapy)

8/2011Intraperitoneal administration of poly(I:C) with polyethylenimine leads to significant antitumor immunity against murine ovarian tumors.
7/2010Carrageenan as an adjuvant to enhance peptide-based vaccine potency.
1/2010Treatment with imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination.
4/2009Treatment with LL-37 peptide enhances antitumor effects induced by CpG oligodeoxynucleotides against ovarian cancer.
1/2009Combination of apigenin treatment with therapeutic HPV DNA vaccination generates enhanced therapeutic antitumor effects.
8/2008Treatment with proteasome inhibitor bortezomib enhances antigen-specific CD8+ T-cell-mediated antitumor immunity induced by DNA vaccination.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Archana Monie Research Topics

Disease

32Neoplasms (Cancer)
08/2011 - 10/2006
7Infection
04/2010 - 12/2007
6Ovarian Neoplasms (Ovarian Cancer)
08/2011 - 04/2008
1Vaccinia
07/2009

Drug/Important Bio-Agent (IBA)

17AntigensIBA
07/2011 - 12/2007
12DNA (Deoxyribonucleic Acid)IBA
01/2011 - 12/2007
8DNA VaccinesIBA
01/2011 - 12/2007
5VaccinesIBA
04/2010 - 12/2007
4Proteins (Proteins, Gene)IBA
04/2010 - 12/2007
4CalreticulinIBA
01/2010 - 05/2008
3Oncogene Proteins (Oncogene Protein)IBA
04/2010 - 04/2008
3Papillomavirus Vaccines (HPV Vaccines)IBA
04/2010 - 04/2008
2Poly I-CIBA
08/2011 - 01/2010
25,6-dimethylxanthenoneacetic acidIBA
07/2011 - 01/2011
2OvalbuminIBA
04/2010 - 07/2009
2Cisplatin (Platino)FDA LinkGeneric
05/2009 - 05/2008
2HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
01/2009 - 01/2009
2A-Form DNA (A-DNA)IBA
01/2009 - 08/2008
2type 6,11,16,18 human papillomavirus vaccine L1 (Gardasil)FDA Link
12/2007 - 10/2006
1Toll-Like Receptor 3IBA
08/2011
1PolyethyleneimineIBA
08/2011
1Nucleic AcidsIBA
08/2011
1CytokinesIBA
07/2011
1Human papillomavirus type 16 oncogene protein E7IBA
07/2011
1CarrageenanIBA
07/2010
1imiquimod (Aldara)FDA LinkGeneric
01/2010
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2010
1PADRE 45IBA
01/2010
1LuciferasesIBA
01/2010
1Neoplasm Antigens (Tumor Antigens)IBA
07/2009
1LigandsIBA
04/2009
1Toll-Like Receptors (Toll-Like Receptor)IBA
04/2009
1CAP18 lipopolysaccharide-binding protein (Bac4)IBA
04/2009
1CPG-oligonucleotideIBA
04/2009
1OligodeoxyribonucleotidesIBA
04/2009
1ApigeninIBA
01/2009
1Interleukin-15 (Interleukin 15)IBA
12/2008
1Tumor Viral Antigens (Large T Antigen)IBA
10/2008
1Combined VaccinesIBA
10/2008
1alpha-galactosylceramideIBA
10/2008
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
08/2008
1AntibodiesIBA
08/2008
1Proteasome Endopeptidase Complex (Proteasome)IBA
08/2008
1bortezomib (Velcade)FDA Link
08/2008
1Viral ProteinsIBA
04/2008
1megakaryocyte potentiating factorIBA
04/2008
118 L1 type 16 human papillomavirus vaccine (Cervarix)IBA
03/2008
1Neutralizing AntibodiesIBA
01/2008
1Carbon MonoxideIBA
12/2007
1Interleukin-2 (IL2)IBA
12/2007
1Viral DNAIBA
08/2007

Therapy/Procedure

18Immunotherapy
08/2011 - 12/2007
6Investigational Therapies (Experimental Therapy)
08/2011 - 08/2008
4Drug Therapy (Chemotherapy)
01/2010 - 05/2008
1Radiotherapy
05/2009
1Complementary Therapies (Alternative Medicine)
10/2008